… -specific mortality in the older thyroid cancer patient group (>45 … -up for thyroid cancer since
low-risk thyroid cancer is associated with … It appears clear despite the weakness and lack of …

… -controlled trial was to evaluate the risks/benefits of prophylactic central neck dissection (pCND)
in patients with clinically node negative (cN0) papillary thyroid cancer (PTC). …

… No prospective clinical studies evaluating the benefits of TSH suppression in patients with
thyroid cancer are available. Mazzaferri [111] and Massin et al. [101], however, have reported …

… benefit of each individual patient rather than the interests of society. Clearly, some thyroid
cancers … about the benefits of surgical intervention for low-risk thyroid cancers, especially PTC. …

… who are unlikely to benefit from radioactive … clear, but many believe it is due to the widespread
use of radiology tests done for other reasons that detect small nonpalpable thyroid cancers…

… It is clear that the surgical and non-surgical treatment of DTC is associated with significant
… Application of treatment is only justifiable when benefit may be reasonably anticipated. Over …

… Notably, a multicenter prospective study of 617 papillary thyroid cancer (PTC) patients showed
that only advanced stage III and IV patients can benefit from <0.1 mU/L TSH suppression, …

… There may well be subgroups, however, where bilobar removal or total thyroidectomy has
a clear benefit. In a subset of 121 patients with higher-risk scores (>4), the above group had a …

… for RAI based on studies showing no survival benefit or reduction in residual/recurrent disease
… Finally, it is not yet clear if particular genomic features of thyroid cancers should influence …

… is not, and the lack of a clear prognostic indication has led to … of thyroid cancer and, arguably,
survival (4,10,11). … outcomes in large cohorts of thyroid cancer patients treated during the …